Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and ...

If cystatin C is not available, a creatinine-based estimated glomerular filtration rate (eGFR) should be used to assess patients at risk for CKD. But if it is available, GFR should be estimated ...

It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1.73 m 2 ... estimated glomerular filtration rate cut-offs. In light of the lipid benefits ...

Risk stratification by two-dimensional information on eGFR and proteinuria can improve the prediction of progression to ESRD; revision of CKD classification by including albuminuria, particular in ...

Toshiharu Ninomiya and colleagues have found that urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) predict cardiovascular and renal risk in individuals ...

"Evaluation of CKD emphasizes the role of cystatin C for better accuracy of GFR, especially in clinical situations where creatinine falls short." More information: Magdalena Madero et al ...

Chronic Kidney Disease (CKD) signifies persistent kidney damage lasting over three months. The best indicator of kidney function is the Glomerular Filtration Rate (GFR), which measures how ...

According to an important study performed by the International Society of Nephrology (ISN), StatSensor Creatinine/eGFR can be effectively used to improve the early detection of CKD and high-risk ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in February ...

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm occurs. Key risk factors include diabetes, high blood pressure, and obesity.